PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 11, 1999New England Journal of Medicine5,246 citationsOpen Access

A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care

View Full Paper
PHPaul C. HébertGWGeorge A. WellsMBMorris A. Blajchman

Key Points

  • To determine whether a restrictive red-cell transfusion strategy produces equivalent 30-day mortality and organ dysfunction outcomes compared to a liberal transfusion strategy in critically ill patients.
  • Multicenter randomized controlled trial of 838 euvolemic critically ill patients with hemoglobin levels <9.0 g/dL within 72 hours of intensive care unit admission.
  • Randomly assigned 418 patients to a restrictive strategy (transfusion threshold <7.0 g/dL, target 7.0–9.0 g/dL) and 420 patients to a liberal strategy (threshold <10.0 g/dL, target 10.0–12.0 g/dL).
  • Overall 30-day mortality was 18.7% in the restrictive-strategy group compared to 23.3% in the liberal-strategy group (P=0.11).
  • In-hospital mortality was significantly lower in the restrictive group than in the liberal group (22.3% vs. 28.1%, P=0.05).
  • Restrictive transfusion significantly lowered 30-day mortality in patients with APACHE II scores ≤20 (8.7% vs. 16.1%, P=0.03) and patients <55 years of age (5.7% vs. 13.0%, P=0.02), with no significant difference among patients with cardiac disease (20.5% vs. 22.9%, P=0.69).

Abstract

BACKGROUND: To determine whether a restrictive strategy of red-cell transfusion and a liberal strategy produced equivalent results in critically ill patients, we compared the rates of death from all causes at 30 days and the severity of organ dysfunction. METHODS: We enrolled 838 critically ill patients with euvolemia after initial treatment who had hemoglobin concentrations of less than 9.0 g per deciliter within 72 hours after admission to the intensive care unit and randomly assigned 418 patients to a restrictive strategy of transfusion, in which red cells were transfused if the hemoglobin concentration dropped below 7.0 g per deciliter and hemoglobin concentrations were maintained at 7.0 to 9.0 g per deciliter, and 420 patients to a liberal strategy, in which transfusions were given when the hemoglobin concentration fell below 10.0 g per deciliter and hemoglobin concentrations were maintained at 10.0 to 12.0 g per deciliter. RESULTS: Overall, 30-day mortality was similar in the two groups (18.7 percent vs. 23.3 percent, P= 0.11). However, the rates were significantly lower with the restrictive transfusion strategy among patients who were less acutely ill -- those with an Acute Physiology and Chronic Health Evaluation II score of < or =20 (8.7 percent in the restrictive-strategy group and 16.1 percent in the liberal-strategy group; P=0.03) -- and among patients who were less than 55 years of age (5.7 percent and 13.0 percent, respectively; P=0.02), but not among patients with clinically significant cardiac disease (20.5 percent and 22.9 percent, respectively; P=0.69). The mortality rate during hospitalization was significantly lower in the restrictive-strategy group (22.3 percent vs. 28.1 percent, P=0.05). CONCLUSIONS: A restrictive strategy of red-cell transfusion is at least as effective as and possibly superior to a liberal transfusion strategy in critically ill patients, with the possible exception of patients with acute myocardial infarction and unstable angina.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hébert et al. (1999) studied this question.

synapsesocial.com/papers/69f933b25a4050c311d4b225https://doi.org/10.1056/nejm199902113400601
Ask AI
Helpful
Bookmark
Share
View Full Paper